1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Keratoconjunctivitis Sicca: new trials by email Literature Review of Keratoconjunctivitis Sicca trials Research Report on Keratoconjunctivitis Sicca
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Of Tasocitinib In Dry Eye Subjects Tasocitinib, vehicle for Tasocitinib - Keratoconjunctivitis Sicca | Phase 2 | Withdrawn | Pfizer | 2010-12-01 | 2018-11-29 |
Conjunctival Diseases (1) · Conjunctivitis (1) · Corneal Diseases (1) · Eye Diseases (1) · Keratitis (1) · Keratoconjunctivitis (1) · Lacrimal Apparatus Diseases (1)
tofacitinib (1)
Pfizer (1)